XML 22 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ (148,908) $ (15,437) $ 18,119
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 20,779 28,007 25,697
Impairment charge 110,658 13,267 1,600
Deferred income taxes (10,281) (10,965) (3,708)
Non-cash interest 284 355 1,314
Amortization of syndication contracts 450 471 468
Payments on syndication contracts (451) (480) (470)
Non-cash stock-based compensation 13,848 23,698 20,034
(Gain) loss on marketable securities 110 93 532
(Gain) loss on disposal of property and equipment 277 737 (636)
Loss (gain) on the sale of businesses 45,187    
(Gain) loss on debt extinguishment 91 1,556  
Change in fair value of contingent consideration (13,198) (2,539) 14,210
Net income (loss) attributable to noncontrolling interest - discontinued operations (2,779) 158  
Net income (loss) attributable to noncontrolling interest - discontinued operations   (342) 2,050
Changes in assets and liabilities, net of businesses acquired and disposed of:      
(Increase) decrease in trade receivables, net 10,092 (9,247) (9,687)
(Increase) decrease in prepaid expenses and other current assets, operating leases right of use asset and other assets 9,878 7,826 2,017
Increase (decrease) in accounts payable, accrued expenses and other liabilities 38,668 38,038 7,377
Net cash provided by operating activities 74,705 75,196 78,917
Cash flows from investing activities:      
Proceeds from sale of assets/business, net of cash divested (40,481) 258 2,708
Purchases of property and equipment (8,463) (27,327) (11,468)
Purchase of businesses, net of cash acquired   (6,930)  
Investment in variable interest entities, net of cash consolidated     (5,164)
Purchases of marketable securities (2,303) (11,355) (106,382)
Proceeds from sale of marketable securities 10,789 43,335 59,814
Proceeds from loan receivable 13,636    
Purchases of investments   (300)  
Issuance of loan receivable   (13,636)  
Net cash provided by (used in) investing activities (26,822) (15,955) (60,492)
Cash flows from financing activities:      
Proceeds from stock option exercises   554 219
Tax payments related to shares withheld for share-based compensation plans (2,564) (4,057) (4,524)
Payments on debt (20,275) (215,745) (3,252)
Dividends paid (17,975) (17,588) (8,539)
Distributions to noncontrolling interest (1,078) (3,380)  
Repurchase of Class A common stock     (11,280)
Payment of contingent consideration (15,650) (35,113) (65,340)
Principal payments under finance lease obligation (148) (152) (105)
Proceeds from borrowings on debt   213,087  
Payments for debt issuance costs   (1,777)  
Net cash used in financing activities (57,690) (64,171) (92,821)
Effect of exchange rates on cash, cash equivalents and restricted cash (2) (5) (3)
Net increase (decrease) in cash, cash equivalents and restricted cash (9,809) (4,935) (74,399)
Cash, cash equivalents and restricted cash:      
Beginning 106,509 111,444 185,843
Ending 96,700 106,509 111,444
Cash payments for:      
Interest 16,407 16,936 9,562
Income taxes 9,413 13,100 16,921
Supplemental disclosures of non-cash investing and financing activities:      
Capital expenditures financed through accounts payable, accrued expenses and other liabilities 1,096 1,987 $ 2,109
Fair value of contingent consideration related to acquisitions and purchase of noncontrolling interest   1,854  
Fair value of put and call option   43,600  
Dividends equivalents payable $ 1,287 $ 783